CTHIn ForceLegislation
National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No.1)
Part 1Bacterial vaccines
Start here
Get a plain-English read of Part 1
Turn the raw legal text into a practical explanation grounded in National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No.1).
Part 1 Bacterial vaccines
| Item | Vaccine and the circumstances in which vaccine may be provided | Brand | Formulation | Active ingredient and strength | Number and timing of doses |
|---|---|---|---|---|---|
| 101 | VaccineDiphtheria, tetanus and pertussis (adult/adolescent)CircumstancesVaccine may be provided to:(a) a child who is at least 10 years but less than 18 years old; or(b) a person who is pregnant. | Boostrix | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 2 IU;(b) tetanus toxoid — not less than 20 IU;(c) PT — 8 µg;(d) FHA — 8 µg;(e) PRN — 2.5 µg | 1 dose (booster) |
| 102 | VaccineDiphtheria, tetanus and pertussis (adult/adolescent)CircumstancesVaccine may be provided to:(a) a child who is at least 10 years but less than 18 years old; or(b) a person who is pregnant. | Adacel | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 2 IU;(b) tetanus toxoid — not less than 20 IU;(c) PT — 2.5 µg;(d) FHA — 5 µg;(e) PRN — 3 µg(f) FIM 2+3 — 5 µg | 1 dose (booster) |
| 102A | VaccineDiphtheria, tetanus and pertussis (child)CircumstancesVaccine may be provided to a child who is about 18 months of age. | Infanrix | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 25 µg;(d) FHA — 25 µg;(e) PRN — 8 µg | 1 dose (booster) |
| 102B | VaccineDiphtheria, tetanus and pertussis (child)CircumstancesVaccine may be provided to a child who is about 18 months of age. | Tripacel | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 10 µg;(d) FHA — 5 µg;(e) PRN — 3 µg(f) FIM 2+3 — 5 µg | 1 dose (booster) |
| 103 | VaccineHaemophilus influenzae type b (Hib) (monovalent PRP‑T)CircumstancesVaccine may be provided to:(a) a child who is about 18 months old; or(b) a person who is at least 5 years old and who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia and did not receive childhood vaccinations; or(c) a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab. |